FdaNdcDirectoryPulse / compare
BRYTLY vs Strophanthus 4X: FdaNdcDirectoryPulse comparison
BRYTLY (2026-10-16) and Strophanthus 4X (2026-10-06) are peer FdaNdcDirectoryPulse records.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Both records plus every comparable record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does BRYTLY compare to Strophanthus 4X?
| Field | BRYTLY | Strophanthus 4X |
|---|---|---|
| Product | BRYTLY | Strophanthus 4X |
| Generic name | Apraclonidine Hydrochloride | Strophanthus kombe 4X |
| NDC | 0065-8596 | 53645-2142 |
| Labeler | Alcon Laboratories, Inc. | True Botanica, LLC |
| Product type | HUMAN OTC DRUG | HUMAN OTC DRUG |
| Approval pathway | NDA | UNAPPROVED HOMEOPATHIC |
| Application number | NDA220341 | |
| Dosage form | SOLUTION/ DROPS | LIQUID |
| Route | OPHTHALMIC | ORAL |
| Active ingredients | APRACLONIDINE HYDROCHLORIDE 1.25 mg/mL | STROPHANTHUS KOMBE SEED 4 [hp_X]/55mL |
| Marketing start | 2026-10-16 | 2026-10-06 |
| Package configurations | 3 | 1 |
| Launch Signal Score | 45/100 | 15/100 |
| Peer rank and all 500 records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: BRYTLY · Strophanthus 4X
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.